SGYP setting up a daily bullish bat LONG pattern going into May 20th, 2015, conference. Paulson & Co. took a 2 million share long position according to 13-F. Company has two GI drugs in phase 3 pipeline and is open to acquisition as peer Salix was acquired recently. $4.84-$5.24 upside target projections.